Neurostimulation Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
세계 신경 자극기 시장 규모는 2024년에 67억 달러에 달할 것으로 보이며, 2024-2031년의 예측기간에 11.7%의 연평균 복합 성장률(CAGR)로 확대되어 2031년에는 146억 달러에 달할 것으로 예측됩니다.
신경 자극기는 만성 통증, 간질, 파킨슨 병, 우울증 등 다양한 신경 질환과 증상의 치료에 필수적입니다. 이 장비는 신경계의 특정 부위에 전기 자극을 주고 신경 활동을 조절하고 증상을 완화하며 환자의 QOL을 향상시킵니다. 신경 자극기 시장은 척수자극기, 뇌심부자극기, 미주신경 자극기 등 다양한 장치를 제공해 병원, 진료소, 재택개호 현장에 대응하고 있습니다. 시장 성장의 원동력은 신경 질환의 유병률 증가, 장치 기술의 진보, 효과적인 치료 수단으로서의 신경 자극에 대한 인식 증가입니다.
세계의 신경 자극기 시장은 만성통증, 간질, 파킨슨병 등 신경질환의 이환율 상승 등 몇 가지 중요한 요인에 의해 추진되고 있습니다. 침습성이 낮은 치료 옵션에 대한 수요 증가, 장치 소형화, 충전식 배터리 및 무선 연결의 발전으로 환자의 편안함이 향상되고 시장 도입이 확대되고 있습니다. 게다가 노인 인구 증가와 의료비 증가는 효과적이고 장기적인 신경학적 치료에 대한 수요를 촉진하고 시장 성장을 더욱 촉진하고 있습니다.
신경 자극기 시장에서의 큰 기회는 기술적 진보, 용도의 확대, 양호한 인구동향으로 인해 발생하고 있는 가능성을 이끌어냅니다. 중재활, 편두통 치료 등의 증상에서의 신경자극의 새로운 응용이 시장의 범위를 넓혀가고 있습니다. 성장과 혁신의 경로를 만들고 있습니다.
본 보고서는 세계의 신경 자극기 시장에 대해 조사했으며, 제품 유형별, 용도별, 지역별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.
목차
제1장 주요 요약
제2장 시장 개요
- 시장의 범위와 정의
- 시장 역학
- 거시경제 요인
- COVID-19의 영향 분석
- 예측 요인- 관련성과 영향
제3장 부가가치 통찰
- 제품 채용 분석
- 기술평가
- 규제 상황
- 밸류체인 분석
- 주요 거래와 합병
- PESTLE 분석
- Porter's Five Forces 분석
제4장 가격 동향 분석, 2019-2031년
제5장 세계의 신경 자극기 시장 전망: 실적(2019-2023년) 및 예측(2024-2031년)
- 주요 하이라이트
- 시장 규모(10억 달러) 분석과 예측
- 세계의 신경 자극기 시장 전망: 제품 유형별
- 세계의 신경 자극기 시장 전망: 용도별
- 시장의 매력 분석 : 용도별
- 세계의 신경 자극기 시장 전망: 최종 사용자별
- 시장의 매력 분석 : 최종 사용자별
제6장 세계의 신경 자극기 시장 전망: 지역별
- 주요 하이라이트
- 과거 시장 규모(10억 달러)와 수량(대)의 분석, 지역별, 2019-2023년
- 현재 시장 규모(10억 달러)와 수량(대)의 분석과 예측, 지역별, 2023-2031년
- 시장의 매력 분석 : 지역별
제7장 북미의 신경 자극기 시장 전망: 실적(2019-2023년) 및 예측(2024-2031년)
제8장 유럽의 신경 자극기 시장 전망: 실적(2019-2023년) 및 예측(2024-2031년)
제9장 동아시아의 신경 자극기 시장 전망: 실적(2019-2023년) 및 예측(2024-2031년)
제10장 남아시아 및 오세아니아의 신경 자극기 시장 전망: 실적(2019-2023년) 및 예측(2024-2031년)
제11장 라틴아메리카의 신경 자극기 시장 전망: 실적(2019-2023년) 및 예측(2024-2031년)
제12장 중동 및 아프리카의 신경 자극기 시장 전망: 실적(2019-2023년) 및 예측(2024-2031년)
제13장 경쟁 구도
- 시장 점유율 분석, 2023년
- 시장 구조
- 기업 프로파일(상세 - 개요, 재무, 전략, 최근 동향)
- Medtronic
- Abbott
- Boston Scientific Corporation
- Cochlear Inc.
- NDI Medical LLC
- NeuroPace Inc.
- MED-EL Medical Electronics
- NeuroSigma Inc.
제14장 부록
JHS
Persistence Market Research has recently released a comprehensive report on the worldwide market for neurostimulation devices. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global neurostimulation devices market from 2024 to 2031.
Key Insights:
- Neurostimulation Devices Market Size (2024E):US$ 6.7 Bn
- Projected Market Value (2031F): US$ 14.6 Bn
- Global Market Growth Rate (CAGR 2024 to 2031): 11.7%
Neurostimulation Devices Market - Report Scope:
Neurostimulation devices are critical in treating various neurological disorders and conditions, including chronic pain, epilepsy, Parkinson's disease, and depression. These devices deliver electrical stimulation to specific areas of the nervous system to modulate neural activity, alleviate symptoms, and improve patient quality of life. The neurostimulation devices market caters to hospitals, clinics, and homecare settings, offering a variety of devices such as spinal cord stimulators, deep brain stimulators, and vagus nerve stimulators. Market growth is driven by the increasing prevalence of neurological disorders, advancements in device technology, and growing awareness of neurostimulation as an effective treatment modality.
Market Growth Drivers:
The global neurostimulation devices market is propelled by several key factors, including the rising incidence of chronic pain and neurological disorders, such as epilepsy and Parkinson's disease. Increasing demand for minimally invasive treatment options and advancements in device miniaturization, rechargeable batteries, and wireless connectivity are enhancing patient comfort and expanding market adoption. Additionally, the growing geriatric population and increasing healthcare expenditure are driving the demand for effective and long-term neurological treatments, further fueling market growth.
Market Restraints:
Despite promising growth prospects, the neurostimulation devices market faces challenges, including high device costs, regulatory hurdles, and potential side effects associated with neurostimulation therapy. Limited access to advanced healthcare infrastructure in developing regions and the lengthy approval process for new devices can restrict market growth. Furthermore, reimbursement constraints and patient skepticism regarding device implantation present additional barriers to widespread adoption.
Market Opportunities:
Significant opportunities in the neurostimulation devices market stem from technological advancements, expanding applications, and favorable demographic trends. Innovations in device design, such as non-invasive stimulation techniques, artificial intelligence integration, and improved patient monitoring capabilities, are unlocking new potential. Emerging applications of neurostimulation in conditions like obesity management, stroke rehabilitation, and migraine treatment broaden the market scope. Moreover, increasing investments in R&D and strategic collaborations among industry players create pathways for growth and innovation in the dynamic neurostimulation landscape.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the neurostimulation devices market globally?
- Which device types and applications are propelling neurostimulation adoption across various healthcare settings?
- How are technological advancements shaping the competitive landscape of the neurostimulation devices market?
- Who are the key players in the market, and what strategies are they employing to maintain competitiveness?
- What are the emerging trends and future prospects in the global neurostimulation devices market?
Competitive Intelligence and Business Strategy:
Leading players in the global neurostimulation devices market, including Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, and Nevro Corp., focus on innovation and strategic partnerships to strengthen their market positions. These companies are investing heavily in R&D to develop advanced neurostimulation solutions, such as closed-loop systems, wearable stimulators, and devices with enhanced connectivity. Collaborations with healthcare providers, research institutions, and regulatory agencies enable market access and facilitate the adoption of cutting-edge technologies. Emphasis on patient education, clinical research, and evidence-based practice further supports market expansion and improved patient outcomes.
Key Companies Profiled:
- Medtronic PLC
- Boston Scientific Corporation
- Abbott Laboratories
- Nevro Corp.
- LivaNova PLC
- Cyberonics, Inc.
- Stimwave LLC
- NeuroPace, Inc.
- Synapse Biomedical Inc.
Neurostimulation Devices Industry Segmentation
By Product Type
- Spinal Cord Stimulators (SCS)
- Deep Brain Stimulators (DBS)
- Vagus Nerve Stimulators (VNS)
- Sacral Nerve Stimulators
- Transcranial Magnetic Stimulation (TMS) Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
By Application
- Pain Management
- Epilepsy
- Depression
- Parkinson's Disease
By End User
- Hospitals
- Clinics
- Homecare Settings
- Research Institutes
By Region
- North America
- Europe
- Latin America
- East Asia
- South Asia and Oceania
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Global Neurostimulation Devices Market Snapshot, 2024 and 2031
- 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.3.3. Global Healthcare Spending Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
- 3.1. Product Adoption Analysis
- 3.2. Technology Assessment
- 3.3. Regulatory Landscape
- 3.4. Value Chain Analysis
- 3.5. Key Deals and Mergers
- 3.6. PESTLE Analysis
- 3.7. Porter's Five Force Analysis
4. Price Trend Analysis, 2019 - 2031
- 4.1. Key Highlights
- 4.2. Key Factors Impacting Product Prices
- 4.3. Pricing Analysis, By Product Type
- 4.4. Regional Prices and Product Type Preferences
5. Global Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
- 5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
- 5.2. Market Size (US$ Bn) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
- 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
- 5.3. Global Neurostimulation Devices Market Outlook: Product Type
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product Type, 2019 - 2023
- 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
- 5.3.3.1. Spinal Cord Stimulators (SCS)
- 5.3.3.2. Deep Brain Stimulators (DBS)
- 5.3.3.3. Vagus Nerve Stimulators (VNS)
- 5.3.3.4. Sacral Nerve Stimulators
- 5.3.3.5. Transcranial Magnetic Stimulation (TMS) Devices
- 5.3.3.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- 5.3.4. Market Attractiveness Analysis: Product Type
- 5.4. Global Neurostimulation Devices Market Outlook: Application
- 5.4.1. Introduction / Key Findings
- 5.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
- 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 5.4.3.1. Pain Management
- 5.4.3.2. Epilepsy
- 5.4.3.3. Depression
- 5.4.3.4. Parkinson's Disease
- 5.4.3.5. Others
- 5.5. Market Attractiveness Analysis: Application
- 5.6. Global Neurostimulation Devices Market Outlook: End User
- 5.6.1. Introduction / Key Findings
- 5.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
- 5.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 5.6.3.1. Hospitals
- 5.6.3.2. Clinics
- 5.6.3.3. Homecare Settings
- 5.6.3.4. Research Institutes
- 5.7. Market Attractiveness Analysis: End User
6. Global Neurostimulation Devices Market Outlook: Region
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2023
- 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2023 - 2031
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
- 6.4. Market Attractiveness Analysis: Region
7. North America Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Bn) and Analysis, By Market, 2019 - 2023
- 7.2.1. By Country
- 7.2.2. By Product Type
- 7.2.3. By Application
- 7.2.4. By End User
- 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
- 7.3.1. U.S.
- 7.3.2. Canada
- 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
- 7.4.1. Spinal Cord Stimulators (SCS)
- 7.4.2. Deep Brain Stimulators (DBS)
- 7.4.3. Vagus Nerve Stimulators (VNS)
- 7.4.4. Sacral Nerve Stimulators
- 7.4.5. Transcranial Magnetic Stimulation (TMS) Devices
- 7.4.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 7.5.1. Pain Management
- 7.5.2. Epilepsy
- 7.5.3. Depression
- 7.5.4. Parkinson's Disease
- 7.5.5. Others
- 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 7.6.1. Hospitals
- 7.6.2. Clinics
- 7.6.3. Homecare Settings
- 7.6.4. Research Institutes
- 7.7. Market Attractiveness Analysis
8. Europe Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
- 8.1. Key Highlights
- 8.2. Pricing Analysis
- 8.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 8.3.1. By Country
- 8.3.2. By Product Type
- 8.3.3. By Application
- 8.3.4. By End User
- 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. U.K.
- 8.4.4. Italy
- 8.4.5. Spain
- 8.4.6. Russia
- 8.4.7. Turkey
- 8.4.8. Rest of Europe
- 8.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
- 8.5.1. Spinal Cord Stimulators (SCS)
- 8.5.2. Deep Brain Stimulators (DBS)
- 8.5.3. Vagus Nerve Stimulators (VNS)
- 8.5.4. Sacral Nerve Stimulators
- 8.5.5. Transcranial Magnetic Stimulation (TMS) Devices
- 8.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 8.6.1. Pain Management
- 8.6.2. Epilepsy
- 8.6.3. Depression
- 8.6.4. Parkinson's Disease
- 8.6.5. Others
- 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 8.7.1. Hospitals
- 8.7.2. Clinics
- 8.7.3. Homecare Settings
- 8.7.4. Research Institutes
- 8.8. Market Attractiveness Analysis
9. East Asia Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
- 9.1. Key Highlights
- 9.2. Pricing Analysis
- 9.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 9.3.1. By Country
- 9.3.2. By Product Type
- 9.3.3. By Application
- 9.3.4. By End User
- 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. South Korea
- 9.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
- 9.5.1. Spinal Cord Stimulators (SCS)
- 9.5.2. Deep Brain Stimulators (DBS)
- 9.5.3. Vagus Nerve Stimulators (VNS)
- 9.5.4. Sacral Nerve Stimulators
- 9.5.5. Transcranial Magnetic Stimulation (TMS) Devices
- 9.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 9.6.1. Pain Management
- 9.6.2. Epilepsy
- 9.6.3. Depression
- 9.6.4. Parkinson's Disease
- 9.6.5. Others
- 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 9.7.1. Hospitals
- 9.7.2. Clinics
- 9.7.3. Homecare Settings
- 9.7.4. Research Institutes
- 9.8. Market Attractiveness Analysis
10. South Asia & Oceania Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 10.2.1. By Country
- 10.2.2. By Product Type
- 10.2.3. By Application
- 10.2.4. By End User
- 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
- 10.3.1. India
- 10.3.2. SEA
- 10.3.3. ANZ
- 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
- 10.4.1. Spinal Cord Stimulators (SCS)
- 10.4.2. Deep Brain Stimulators (DBS)
- 10.4.3. Vagus Nerve Stimulators (VNS)
- 10.4.4. Sacral Nerve Stimulators
- 10.4.5. Transcranial Magnetic Stimulation (TMS) Devices
- 10.4.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 10.5.1. Pain Management
- 10.5.2. Epilepsy
- 10.5.3. Depression
- 10.5.4. Parkinson's Disease
- 10.5.5. Others
- 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 10.6.1. Hospitals
- 10.6.2. Clinics
- 10.6.3. Homecare Settings
- 10.6.4. Research Institutes
11. Latin America Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
- 11.1. Key Highlights
- 11.2. Pricing Analysis
- 11.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 11.3.1. By Country
- 11.3.2. By Product Type
- 11.3.3. By Application
- 11.3.4. By End User
- 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
- 11.4.1. Brazil
- 11.4.2. Mexico
- 11.4.3. Rest of Latin America
- 11.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
- 11.5.1. Spinal Cord Stimulators (SCS)
- 11.5.2. Deep Brain Stimulators (DBS)
- 11.5.3. Vagus Nerve Stimulators (VNS)
- 11.5.4. Sacral Nerve Stimulators
- 11.5.5. Transcranial Magnetic Stimulation (TMS) Devices
- 11.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 11.6.1. Pain Management
- 11.6.2. Epilepsy
- 11.6.3. Depression
- 11.6.4. Parkinson's Disease
- 11.6.5. Others
- 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 11.7.1. Hospitals
- 11.7.2. Clinics
- 11.7.3. Homecare Settings
- 11.7.4. Research Institutes
- 11.8. Market Attractiveness Analysis
12. Middle East & Africa Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
- 12.1. Key Highlights
- 12.2. Pricing Analysis
- 12.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
- 12.3.1. By Country
- 12.3.2. By Product Type
- 12.3.3. By Application
- 12.3.4. By End User
- 12.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
- 12.4.1. GCC Countries
- 12.4.2. Egypt
- 12.4.3. South Africa
- 12.4.4. Northern Africa
- 12.4.5. Rest of Middle East & Africa
- 12.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
- 12.5.1. Spinal Cord Stimulators (SCS)
- 12.5.2. Deep Brain Stimulators (DBS)
- 12.5.3. Vagus Nerve Stimulators (VNS)
- 12.5.4. Sacral Nerve Stimulators
- 12.5.5. Transcranial Magnetic Stimulation (TMS) Devices
- 12.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
- 12.6.1. Pain Management
- 12.6.2. Epilepsy
- 12.6.3. Depression
- 12.6.4. Parkinson's Disease
- 12.6.5. Others
- 12.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
- 12.7.1. Hospitals
- 12.7.2. Clinics
- 12.7.3. Homecare Settings
- 12.7.4. Research Institutes
- 12.8. Market Attractiveness Analysis
13. Competition Landscape
- 13.1. Market Share Analysis, 2023
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
- 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Medtronic
- 13.3.1.1. Overview
- 13.3.1.2. Segments and Product Types
- 13.3.1.3. Key Financials
- 13.3.1.4. Market Developments
- 13.3.1.5. Market Strategy
- 13.3.2. Abbott
- 13.3.3. Boston Scientific Corporation
- 13.3.4. Cochlear Inc.
- 13.3.5. NDI Medical LLC
- 13.3.6. NeuroPace Inc.
- 13.3.7. MED-EL Medical Electronics
- 13.3.8. NeuroSigma Inc.
14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms and Abbreviations
